Clinical application of nonvascularized toe phalangeal transfer for treatment of congenital symbrachydactyly in infants and children

刘英男,徐秀玥,魏瑞鸿,谭周勇,徐滔,刘兆康,庄永青,柯燕娜,劳杰,方有生
DOI: https://doi.org/10.3760/cma.j.cn311653-20210707-00215
2022-01-01
Abstract:Objective:To investigate the clinical efficacy of nonvascularized toe phalangeal transfer for treatment of congenital symbrachydactyly in infants and children and summarize the experience of surgical treatment.Methods:From May 2016 to December 2019, 8 cases (13 fingers) with congenital symbrachydactyly were treated by nonvascularized toe phalangeal transfer into the soft tissue of affected fingers. The iliac bone was transplanted into the donor area of phalangeal bone. Both donor and recipient areas were fixed with Kirschner wire. The survival, epiphyseal development and finger growth length of free transplanted phalanges were followed up.Results:The follow-up time was 12 months to 4 years, with an average of 24 months. All the 8 cases (13 fingers) survived after operation. There was no premature closure of epiphysis. Bone resorption occurred in one case of iliac bone graft in the donor area of toe. The average extension of the affected finger was 6 mm (range, 4 to 15 mm). The appearance of all the affected fingers was significantly improved and the function was partially restored.Conclusion:The nonvascularized toe phalangeal transfer is an optional method for the treatment of symbrachydactyly in infants and children.
What problem does this paper attempt to address?